Skip to main content
Erschienen in: International Journal of Legal Medicine 2/2012

01.03.2012 | Original Article

Degradation and elimination of succinylcholine and succinylmonocholine and definition of their respective detection windows in blood and urine for forensic purposes

verfasst von: Uta Kuepper, Frank Herbstreit, Jürgen Peters, Burkhard Madea, Frank Musshoff

Erschienen in: International Journal of Legal Medicine | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

The muscle relaxant succinylcholine (SUX) evokes respiratory paralysis, and numerous cases of fatal SUX intoxication have been reported. Detection of SUX and its metabolite succinylmonocholine (SMC) is difficult, both due to their (bis-) quaternary structure and the extreme hydrolytic susceptibility of SUX, and data on degradation kinetics of SUX and SMC is scarce. The present study investigates the in vivo and in vitro degradation as well as elimination of both target analytes using authentic blood and urine samples from anesthetized patients. With a special focus on the urinary data and stabilization issues, this work intends to considerably enhance the forensic knowledge concerning SUX intoxications and to present the reader with practical analytical strategies to cope with such difficult cases. Eighteen subjects undergoing surgery and requiring arterial as well as bladder catheters were included in this study. Muscle relaxation was initialized with a bolus injection of 80–100 mg SUX. Blood and urine samples were either collected using paraoxonized (n = 15) or non-modified (n = 3) tubes. Sampling was performed within 6 h after SUX application following a pre-assigned schedule. Samples were processed according to a validated isotope dilution HPLC–MS/MS method using ion-pair solid-phase extraction. In blood, SUX was usually detectable for up to 10 min post-injection, while detection of SMC was possible over the whole observation period of 6 h. Effectiveness of organophosphate stabilization was proven for both analytes and is therefore recommended. In freshly secreted urine, detection windows of a minimum of 2 h as opposed to 6 h have been determined for SUX versus SMC, respectively. Considering SMC plasma kinetics, detection of the metabolite in blood and freshly secreted urine appears to be possible over a period of at least 8–24 h. Paraoxon did not enhance the stability of either target substance in urine, stabilization of urine samples is nonetheless recommended. In summary, SMC was proven to be the most promising target analyte in SUX analysis, with urine being the proposed matrix of choice for forensic applications. Furthermore, our work defines meaningful detection windows for SUX and SMC in blood and urine as routine matrices and presents sampling recommendations as well as guideline values for forensic toxicological analysis.
Literatur
1.
Zurück zum Zitat Maltby JR (1975) Criminal poisoning with anaesthetic drugs: murder, manslaughter, or not guilty. Forensic Sci 6:91–108PubMedCrossRef Maltby JR (1975) Criminal poisoning with anaesthetic drugs: murder, manslaughter, or not guilty. Forensic Sci 6:91–108PubMedCrossRef
2.
Zurück zum Zitat Strock D, Kuczkowski KM, Greenberg M (2004) Accidental administration of succinylcholine for the treatment of hypotension in a labouring parturient. Can J Anaesth 51:853–854PubMedCrossRef Strock D, Kuczkowski KM, Greenberg M (2004) Accidental administration of succinylcholine for the treatment of hypotension in a labouring parturient. Can J Anaesth 51:853–854PubMedCrossRef
3.
Zurück zum Zitat Somogyi G, Varga M, Prokai L, Dinya Z, Buris L (1989) Drug identification problems in two suicides with neuromuscular blocking agents. Forensic Sci Int 43:257–266PubMedCrossRef Somogyi G, Varga M, Prokai L, Dinya Z, Buris L (1989) Drug identification problems in two suicides with neuromuscular blocking agents. Forensic Sci Int 43:257–266PubMedCrossRef
4.
Zurück zum Zitat Kato M, Shiratori T, Yamamuro M, Haga S, Hoshi K, Matsukawa S, Jalal IM, Hashimoto Y (1999) Comparison between in vivo and in vitro pharmacokinetics of succinylcholine in humans. J Anesth 13:189–192PubMedCrossRef Kato M, Shiratori T, Yamamuro M, Haga S, Hoshi K, Matsukawa S, Jalal IM, Hashimoto Y (1999) Comparison between in vivo and in vitro pharmacokinetics of succinylcholine in humans. J Anesth 13:189–192PubMedCrossRef
5.
Zurück zum Zitat Dal Santo G (1968) Kinetics of distribution of radioactive labeled muscle relaxants. Anesthesiology 29:435–443PubMedCrossRef Dal Santo G (1968) Kinetics of distribution of radioactive labeled muscle relaxants. Anesthesiology 29:435–443PubMedCrossRef
6.
Zurück zum Zitat Pitts NI, Deftereos D, Mitchell G (2000) Determination of succinylcholine in plasma by high-pressure liquid chromatography with electrochemical detection. Br J Anaesth 85:592–598PubMedCrossRef Pitts NI, Deftereos D, Mitchell G (2000) Determination of succinylcholine in plasma by high-pressure liquid chromatography with electrochemical detection. Br J Anaesth 85:592–598PubMedCrossRef
7.
Zurück zum Zitat Torda TA, Graham GG, Warwick NR, Donohue P (1997) Pharmacokinetics and pharmacodynamics of suxamethonium. Anaesth Intensive Care 25:272–278PubMed Torda TA, Graham GG, Warwick NR, Donohue P (1997) Pharmacokinetics and pharmacodynamics of suxamethonium. Anaesth Intensive Care 25:272–278PubMed
8.
Zurück zum Zitat Lagerwerf AJ, Vanlinthout LE, Vree TB (1991) Rapid determination of succinylcholine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 570:390–395PubMedCrossRef Lagerwerf AJ, Vanlinthout LE, Vree TB (1991) Rapid determination of succinylcholine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 570:390–395PubMedCrossRef
9.
Zurück zum Zitat Roy JJ, Boismenu D, Gao H, Mamer OA, Varin F (2001) Measurement of succinylcholine concentration in human plasma by electrospray tandem mass spectrometry. Anal Biochem 290:238–244PubMedCrossRef Roy JJ, Boismenu D, Gao H, Mamer OA, Varin F (2001) Measurement of succinylcholine concentration in human plasma by electrospray tandem mass spectrometry. Anal Biochem 290:238–244PubMedCrossRef
10.
Zurück zum Zitat Roy JJ, Donati F, Boismenu D, Varin F (2002) Concentration–effect relation of succinylcholine chloride during propofol anesthesia. Anesthesiology 97:1082–1092PubMedCrossRef Roy JJ, Donati F, Boismenu D, Varin F (2002) Concentration–effect relation of succinylcholine chloride during propofol anesthesia. Anesthesiology 97:1082–1092PubMedCrossRef
12.
Zurück zum Zitat Foldes FF, Vandervort RS, Shanor SP (1955) The fate of succinylcholine in man. Anesthesiology 16:11–21PubMedCrossRef Foldes FF, Vandervort RS, Shanor SP (1955) The fate of succinylcholine in man. Anesthesiology 16:11–21PubMedCrossRef
13.
Zurück zum Zitat Foldes FF (1953) Succinylmonocholine iodide: its enzymatic hydrolysis and neuromuscular activity. Proc Soc Exp Biol Med 83:187–189PubMed Foldes FF (1953) Succinylmonocholine iodide: its enzymatic hydrolysis and neuromuscular activity. Proc Soc Exp Biol Med 83:187–189PubMed
14.
Zurück zum Zitat Ballard KD, Vickery WE, Nguyen LT, Diamond FX, Rieders F (2006) An analytical strategy for quaternary ammonium neuromuscular blocking agents in a forensic setting using LC-MS/MS on a tandem quadrupole/time-of-flight instrument. J Am Soc Mass Spectrom 17:1456–1468PubMedCrossRef Ballard KD, Vickery WE, Nguyen LT, Diamond FX, Rieders F (2006) An analytical strategy for quaternary ammonium neuromuscular blocking agents in a forensic setting using LC-MS/MS on a tandem quadrupole/time-of-flight instrument. J Am Soc Mass Spectrom 17:1456–1468PubMedCrossRef
15.
Zurück zum Zitat LeBeau M, Quenzer C (2003) Succinylmonocholine identified in negative control tissues. J Anal Toxicol 27:600–601PubMed LeBeau M, Quenzer C (2003) Succinylmonocholine identified in negative control tissues. J Anal Toxicol 27:600–601PubMed
16.
Zurück zum Zitat Kuepper U, Musshoff F, Madea B (2008) A fully validated isotope dilution HPLC-MS/MS method for the simultaneous determination of succinylcholine and succinylmonocholine in serum and urine samples. J Mass Spectrom 43:1344–1352PubMedCrossRef Kuepper U, Musshoff F, Madea B (2008) A fully validated isotope dilution HPLC-MS/MS method for the simultaneous determination of succinylcholine and succinylmonocholine in serum and urine samples. J Mass Spectrom 43:1344–1352PubMedCrossRef
17.
Zurück zum Zitat Kuepper U, Musshoff F, Madea B (2007) Synthesis and characterization of succinylcholine-d(18) and succinylmonocholine-d(3) designed for simultaneous use as internal standards in mass spectrometric analyses. J Mass Spectrom 42:929–939PubMedCrossRef Kuepper U, Musshoff F, Madea B (2007) Synthesis and characterization of succinylcholine-d(18) and succinylmonocholine-d(3) designed for simultaneous use as internal standards in mass spectrometric analyses. J Mass Spectrom 42:929–939PubMedCrossRef
18.
Zurück zum Zitat Kuepper U, Musshoff F, Madea B (2008) Succinylmonocholine analytics as an example for selectivity problems in high-performance liquid chromatography/tandem mass spectrometry, and resulting implications for analytical toxicology. Rapid Commun Mass Spectrom 22:1965–1970PubMedCrossRef Kuepper U, Musshoff F, Madea B (2008) Succinylmonocholine analytics as an example for selectivity problems in high-performance liquid chromatography/tandem mass spectrometry, and resulting implications for analytical toxicology. Rapid Commun Mass Spectrom 22:1965–1970PubMedCrossRef
19.
Zurück zum Zitat Kuepper U, Musshoff F, Hilger RA, Herbstreit F, Madea B (2011) Pharmacokinetic properties of succinylmonocholine in surgical patients. J Anal Toxicol 35:302–311PubMedCrossRef Kuepper U, Musshoff F, Hilger RA, Herbstreit F, Madea B (2011) Pharmacokinetic properties of succinylmonocholine in surgical patients. J Anal Toxicol 35:302–311PubMedCrossRef
20.
Zurück zum Zitat Hoshi K, Hashimoto Y, Matsukawa S (1993) Pharmacokinetics of succinylcholine in man. Tohoku J Exp Med 170:245–250PubMedCrossRef Hoshi K, Hashimoto Y, Matsukawa S (1993) Pharmacokinetics of succinylcholine in man. Tohoku J Exp Med 170:245–250PubMedCrossRef
21.
Zurück zum Zitat Forney RB Jr, Carroll FT, Nordgren IK, Pettersson BM, Holmstedt B (1982) Extraction, identification and quantitation of succinylcholine in embalmed tissue. J Anal Toxicol 6:115–119PubMed Forney RB Jr, Carroll FT, Nordgren IK, Pettersson BM, Holmstedt B (1982) Extraction, identification and quantitation of succinylcholine in embalmed tissue. J Anal Toxicol 6:115–119PubMed
22.
Zurück zum Zitat Nordgren I, Baldwin K, Forney R Jr (1984) Succinylcholine-tissue distribution and elimination from plasma in the dog. Biochem Pharmacol 33:2519–2521PubMedCrossRef Nordgren I, Baldwin K, Forney R Jr (1984) Succinylcholine-tissue distribution and elimination from plasma in the dog. Biochem Pharmacol 33:2519–2521PubMedCrossRef
23.
Zurück zum Zitat Foldes FF, Norton S (1954) The urinary excretion of succinyldicholine and succinylmonocholine in man. Br J Pharmacol Chemother 9:385–388PubMed Foldes FF, Norton S (1954) The urinary excretion of succinyldicholine and succinylmonocholine in man. Br J Pharmacol Chemother 9:385–388PubMed
24.
Zurück zum Zitat Stevens HM, Moffat AC (1974) A rapid screening procedure for quaternary ammonium compounds in fluids and tissues with special reference to suxamethonium (succinylcholine). J Forensic Sci Soc 14:141–148PubMedCrossRef Stevens HM, Moffat AC (1974) A rapid screening procedure for quaternary ammonium compounds in fluids and tissues with special reference to suxamethonium (succinylcholine). J Forensic Sci Soc 14:141–148PubMedCrossRef
25.
Zurück zum Zitat Goedde HW, Held KR, Altland K (1968) Hydrolysis of succinyldicholine and succinylmonocholine in human serum. Mol Pharmacol 4:274–287PubMed Goedde HW, Held KR, Altland K (1968) Hydrolysis of succinyldicholine and succinylmonocholine in human serum. Mol Pharmacol 4:274–287PubMed
26.
Zurück zum Zitat Schmidinger S, Held KR, Goedde HW (1966) Hydrolysis of succinyldicholine by pseudocholinesterase at low concentrations. Humangenetik 2:221–224PubMedCrossRef Schmidinger S, Held KR, Goedde HW (1966) Hydrolysis of succinyldicholine by pseudocholinesterase at low concentrations. Humangenetik 2:221–224PubMedCrossRef
27.
Zurück zum Zitat Tsutsumi H, Nishikawa M, Katagi M, Tsuchihashi H (2003) Adsorption and stability of suxamethonium and its major hydrolysis product succinylmonocholine using liquid chromatography-electrospray ionization mass spectrometry. J Health Sci 49:285–291CrossRef Tsutsumi H, Nishikawa M, Katagi M, Tsuchihashi H (2003) Adsorption and stability of suxamethonium and its major hydrolysis product succinylmonocholine using liquid chromatography-electrospray ionization mass spectrometry. J Health Sci 49:285–291CrossRef
28.
Zurück zum Zitat Mtairag EM, Abdelghaffar H, Labro MT (1994) Investigation of dirithromycin and erythromycylamine uptake by human neutrophils in vitro. J Antimicrob Chemother 33:523–536PubMedCrossRef Mtairag EM, Abdelghaffar H, Labro MT (1994) Investigation of dirithromycin and erythromycylamine uptake by human neutrophils in vitro. J Antimicrob Chemother 33:523–536PubMedCrossRef
29.
Zurück zum Zitat Uetrecht JP (1992) Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis. Drug Saf 7(Suppl 1):51–56PubMedCrossRef Uetrecht JP (1992) Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis. Drug Saf 7(Suppl 1):51–56PubMedCrossRef
30.
Zurück zum Zitat Baldwin KA, Forney R Jr (1988) The influence of storage temperature and chemical preservation on the stability of succinylcholine in canine tissue. J Forensic Sci 33:462–469PubMed Baldwin KA, Forney R Jr (1988) The influence of storage temperature and chemical preservation on the stability of succinylcholine in canine tissue. J Forensic Sci 33:462–469PubMed
Metadaten
Titel
Degradation and elimination of succinylcholine and succinylmonocholine and definition of their respective detection windows in blood and urine for forensic purposes
verfasst von
Uta Kuepper
Frank Herbstreit
Jürgen Peters
Burkhard Madea
Frank Musshoff
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
International Journal of Legal Medicine / Ausgabe 2/2012
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-011-0623-0

Weitere Artikel der Ausgabe 2/2012

International Journal of Legal Medicine 2/2012 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin